Rhumbline Advisers Surmodics Inc Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Surmodics Inc stock. As of the latest transaction made, Rhumbline Advisers holds 20,250 shares of SRDX stock, worth $540,877. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,250
Previous 19,389
4.44%
Holding current value
$540,877
Previous $751,000
6.66%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding SRDX
# of Institutions
141Shares Held
12.1MCall Options Held
31.4KPut Options Held
13.2K-
Black Rock Inc. New York, NY1.17MShares$31.3 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.01MShares$27 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA803KShares$21.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY675KShares$18 Million0.0% of portfolio
-
Qube Research & Technologies LTD London, X0454KShares$12.1 Million0.02% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $374M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...